AbbVie (ABBV) EBIT Margin (2012 - 2026)
AbbVie (ABBV) reported EBIT Margin of 26.6% for Q1 2026, down 138.0% year-over-year from 69.99% in Q1 2025, and down 2.73% on a QoQ basis from 27.34% in Q4 2025.
AbbVie (ABBV) has 15 years of EBIT Margin data on file, last reported at 26.6% in Q1 2026.
- Quarterly EBIT Margin fell 138.0% year-over-year to 26.6% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 24.41% (up 685.0% YoY) and the FY2025 annual result came in at 24.65%, up 843.0% from the prior year.
- EBIT Margin declined to 26.6% in Q1 2026 per ABBV's latest filing, from 27.34% in the prior quarter.
- Across five years, EBIT Margin topped out at 36.39% in Q4 2022 and bottomed at 9.87% in Q4 2024.
- The 5-year median for EBIT Margin is 26.6% (2026), against an average of 24.21%.
- The widest annual swing landed in 2024, when EBIT Margin tumbled 3221 bps; it then surged 3721 bps in 2025.
- Tracing ABBV's EBIT Margin over 5 years: stood at 36.39% in 2022, then plunged by 39 bps to 22.34% in 2023, then tumbled by 144 bps to 9.87% in 2024, then soared by 377 bps to 27.34% in 2025, then fell by 3 bps to 26.6% in 2026.
- Per Business Quant, the three latest ABBV EBIT Margin figures stand at 26.6% (Q1 2026), 27.34% (Q4 2025), and 12.07% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 47.98% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 26.44% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 26.60% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -47.46% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 30.94% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 37.16% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -286.83% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -1.58% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.60% |
| Dec 31, 2025 | 27.34% |
| Sep 30, 2025 | 12.07% |
| Jun 30, 2025 | 31.73% |
| Mar 31, 2025 | 27.98% |
| Dec 31, 2024 | -9.87% |
| Sep 30, 2024 | 26.49% |
| Jun 30, 2024 | 27.64% |
| Mar 31, 2024 | 22.73% |
| Dec 31, 2023 | 22.34% |
| Sep 30, 2023 | 16.38% |
| Jun 30, 2023 | 32.55% |
| Mar 31, 2023 | 22.64% |
| Dec 31, 2022 | 36.39% |
| Sep 30, 2022 | 31.08% |
| Jun 30, 2022 | 22.59% |
| Mar 31, 2022 | 34.84% |
| Dec 31, 2021 | 34.09% |
| Sep 30, 2021 | 30.02% |
| Jun 30, 2021 | 31.81% |
| Mar 31, 2021 | 31.54% |
| Dec 31, 2020 | 27.08% |
| Sep 30, 2020 | 25.23% |
| Jun 30, 2020 | 7.21% |
| Mar 31, 2020 | 41.80% |
| Dec 31, 2019 | 45.45% |
| Sep 30, 2019 | 30.86% |
| Jun 30, 2019 | 41.19% |
| Mar 31, 2019 | 38.45% |
| Dec 31, 2018 | -29.39% |
| Sep 30, 2018 | 38.36% |
| Jun 30, 2018 | 33.37% |
| Mar 31, 2018 | 36.59% |
| Dec 31, 2017 | 23.03% |
| Sep 30, 2017 | 38.51% |
| Jun 30, 2017 | 38.34% |
| Mar 31, 2017 | 36.82% |
| Dec 31, 2016 | 34.05% |
| Sep 30, 2016 | 36.71% |
| Jun 30, 2016 | -1.39% |
| Mar 31, 2016 | 38.23% |
| Dec 31, 2015 | 33.02% |
| Sep 30, 2015 | 31.71% |
| Jun 30, 2015 | 314.95% |
| Mar 31, 2015 | 33.47% |
| Dec 31, 2014 | -7.61% |
| Sep 30, 2014 | 19.13% |
| Jun 30, 2014 | 30.76% |
| Mar 31, 2014 | 29.61% |
| Dec 31, 2013 | 30.03% |
| Sep 30, 2013 | 29.43% |
| Jun 30, 2013 | 30.97% |
| Mar 31, 2013 | 30.15% |
| Dec 31, 2012 | 34.98% |
| Sep 30, 2012 | 35.40% |
| Jun 30, 2012 | 31.65% |
| Mar 31, 2012 | 23.44% |